Financials data is unavailable for this security.
View more
Year on year IDEXX Laboratories Inc grew revenues 8.72% from 3.37bn to 3.66bn while net income improved 24.44% from 679.09m to 845.04m.
Gross margin | 60.41% |
---|---|
Net profit margin | 22.34% |
Operating margin | 28.62% |
Return on assets | 26.91% |
---|---|
Return on equity | 63.25% |
Return on investment | 39.47% |
More ▼
Cash flow in USDView more
In 2023, IDEXX Laboratories Inc increased its cash reserves by 303.33%, or 341.39m. The company earned 906.51m from its operations for a Cash Flow Margin of 24.76%. In addition the company used 125.25m on investing activities and also paid 442.00m in financing cash flows.
Cash flow per share | 11.53 |
---|---|
Price/Cash flow per share | 44.03 |
Book value per share | 19.16 |
---|---|
Tangible book value per share | 12.87 |
More ▼
Balance sheet in USDView more
Current ratio | 1.37 |
---|---|
Quick ratio | 1.03 |
Total debt/total equity | 0.5979 |
---|---|
Total debt/total capital | 0.3742 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | 18.62 |
---|---|
EPS (TTM) vs TTM 1 year ago | 7.03 |